Market validation
Test the market before you commit to it
China market validation for IP-driven SMEs considering China entry
China market validation tests whether the conditions for a successful entry actually exist. Most China entry decisions are made incorrectly because the decision is made on assumed rather than validated demand.
Getting that wrong is expensive and slow to reverse: Validation that confirms your assumptions costs weeks, but entry on wrong assumptions costs capital, structure, and time.
What is China market validation
Validation tests whether successful entry is possible
What it tests
Demand, partner capability, and commercial feasibility.
When it is done
What it produces
Who this is relevant for
SMEs with established commercial traction at home.
Companies that have received inbound interest from a Chinese distributor or partner but cannot verify the quality of that interest without in-market assessment.
Founders or commercial directors who have been to China, seen the opportunity, and want to test whether it is real before committing budget and management time.
Companies that have previously attempted China entry and want to approach a second attempt with a structured evidence base rather than revised optimism.
Companies under board or competitor pressure to enter China and needing evidence before they commit.
What validation tests
Three major conditions
Companies typically arrive in China with evidence of interest - inbound enquiries, trade fair conversations, distributor enthusiasm. That evidence is real. But it rarely maps to verified purchasing intent at viable commercial volumes. What appears to be market demand is frequently category curiosity: interest in the product that does not convert into buying behaviour at the price point the commercial model requires.
The diagnostic question
The Shaeps validation process
The output is a decision, not a market report
Scoping
Output: a working business model to test
We describe what business model needs to be demonstrated and tested - buyer segments, how the product should be framed, what partner profile is required.
In-market testing
Output: signals of buyer and partner intent
Evidence is gathered through direct in-market engagement - channel conversations, partner assessments, regulatory mapping, and where possible, commercial signal testing.
Decision
Output: go, no-go, or a refined hypothesis
The decision is structured against the original hypothesis as updated by the evidence. The outcome is go, no-go, or a refined hypothesis that triggers another test cycle. Without this discipline, companies in attractive markets tend to proceed regardless of mixed signals.
The right entry decision comes after validation: Validation determines whether entry should proceed at all, and it shapes the entry plan that follows. Without a validated case, an entry plan is premature.
No cure, no pay
We earn only on commercial outcomes. If the evidence does not support entry, we will say so
